Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine |
| |
Authors: | DeJesus Edwin,Ruane Peter,McDonald Cheryl,Garcia Fernando,Sharma Shetal,Corales Roberto,Ravishankar Jayashree,Khanlou Homayoun,Shamblaw David,Ecker Janet,Ebrahimi Ramin,Flaherty John COMET Study Team |
| |
Affiliation: | Orlando Immunology Center, Orlando, Florida 32803, USA. edelesus@oicorlando.com |
| |
Abstract: | |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|